Global Ibuprofen API Market, By Product (Rx, OTC), Application (Headache, Arthritis, Others), End User (CROs and CMOs, Pharmaceutical and Biopharmaceutical Company), Country (U.S., Canada, Mexico, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Ibuprofen API Market
The ibuprofen API market is expected to witness market growth at a rate of 4.90% in the forecast period of 2021 to 2028 is expected to reach USD 0.570 billion by 2028. Data Bridge Market Research report on ibuprofen API market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the prevalence of chronic diseases globally is escalating the growth of ibuprofen API market.
Ibuprofen refers to a medication in the nonsteroidal anti-inflammatory drug (NSAID) class which is extensively utilized in the treatment for fever, treating pain and inflammation. The medication is generally taken for migraines, painful menstrual periods and rheumatoid arthritis. This could also be used as a patent ductus arteriosus in a premature baby. It could be taken through mouth or intravenously and generally works within an hour.
The rise in the pharmaceutical and biopharmaceutical production across the globe acts as one of the major factors driving the growth of ibuprofen API market. The increase in the incidences of wide range of diseases such as infectious diseases, diabetes, cardiovascular disease and kidney-related complications and the rise in the need for drug development to treat the diseases efficiently accelerate the ibuprofen API market growth. The high utilization of advanced technologies such as bioinformatics, high throughput and combinatorial chemistry for the identification of better drug further influences the ibuprofen API market. Additionally, emerging technologies, growth in awareness regarding diseases and treatments, changing lifestyle, rise in healthcare expenditure and surge in investment for research projects positively affect the ibuprofen API market. Furthermore, research and development activities extend profitable opportunities to the ibuprofen API market players in the forecast period of 2021 to 2028.
On the other hand, the implementations of stringent regulations regarding drugs manufacturing and sales across few regions and fluctuation in demand patterns are the factors expected to obstruct the ibuprofen API market growth. The negative impact of COVID-19 on pharmaceutical and biopharmaceutical sectors among others is projected to challenge the ibuprofen API market in the forecast period of 2021-2028.
This ibuprofen API market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on ibuprofen API market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Ibuprofen API Market Scope and Market Size : Global Ibuprofen API Market
The ibuprofen API market is segmented on the basis of product, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the ibuprofen API market is segmented into Rx and OTC.
- On the basis of application, the ibuprofen API market is segmented into headache, arthritis and others.
- On the basis of end user, the ibuprofen API market is segmented into CROs and CMOs and pharmaceutical and biopharmaceutical company.
Global Ibuprofen API Market Country Level Analysis
The ibuprofen API market is analyzed and market size, volume information is provided by country, product, application and end user as referenced above.
The countries covered in the global ibuprofen API market report are the U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
Asia-Pacific dominates the ibuprofen API market because of the rise in healthcare expenditure, rise in the production facilities, presence of pharmaceutical and biotechnological key plyers and increase in the incidence of rheumatoid arthritis disease and surge in healthcare activities.
The country section of the ibuprofen API market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Ibuprofen API Market Share Analysis
The ibuprofen API market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to ibuprofen API market.
The major players covered in the ibuprofen API market report are BASF SE, SI Group, Inc., BIOCAUSE Inc., IOL Chemicals and Pharmaceuticals Limited, Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd., Solara, Wellona Pharma, Granules India Limited, LGM Pharma, SALVAVIDAS PHARMACEUTICAL PVT. LTD., Sri Krishna Pharmaceuticals Ltd., Taj Pharmaceuticals Limited, AZELIS, Anantco Enterprises Pvt. Ltd. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
